MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools

被引:0
|
作者
Philipp Kollmann
Victor-Felix Mautner
Johannes Koeppen
Ralph Wenzel
Jan M. Friedman
Johannes Salamon
Said Farschtschi
机构
[1] University Medical Center Hamburg-Eppendorf,Department of Neurology
[2] University Medical Center Hamburg-Eppendorf,Department of Neurosurgery
[3] Radiological Practice Altona,Department of Medical Genetics
[4] University of British Columbia,Department of Diagnostic and Interventional Radiology and Nuclear Medicine
[5] University Medical Center Hamburg-Eppendorf,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neurofibromatosis type 2 is a neurogenetic disorder with an incidence of about 1:33.000. Hallmarks are bilateral benign vestibular schwannomas, which can lead to deafness or brainstem compression. Volumetric tumor measurements are essential to assess the efficacy of new therapies. We present a statistical and methodical comparison of three volumetric image analysis tools. We performed volumetric measurements on phantoms with predefined volumes (0.1 to 8.0 ml) and tumors seen on 32 head MRI scans from eight NF2 patients with BrainLab, ITK-Snap, or OsiriX. The software was compared with regard to accuracy and reproducibility of the measurements and time required for analysis. The mean volume estimated by all three software programs differed significantly from the true volume of the phantoms, but OsiriX and BrainLab gave estimates that were not significantly different from each other. For the actual tumors, the estimated volumes with all three software tools showed a low coefficient of variability, but the mean volume estimates differed among the tools. OsiriX showed the shortest analysis time. Volumetric assessment of MRI images is associated to an intrinsic risk of miscalculation. For precise volumes it is mandatory to use the same volumetric tools for all measurements.
引用
收藏
相关论文
共 49 条
  • [31] Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
    Gugel, Isabel
    Kluwe, Lan
    Zipfel, Julian
    Teuber, Christian
    Tatagiba, Marcos
    Mautner, Victor-Felix
    Schuhmann, Martin Ulrich
    Grimm, Florian
    CANCERS, 2019, 11 (12)
  • [32] Long-term results of Gamma-knife stereotactic radiosurgery for vestibular schwannomas in patients with type 2 neurofibromatosis
    Spatola, G.
    Carron, R.
    Delsanti, C.
    Thomassin, J-M
    Roche, P-H
    Regis, J.
    NEUROCHIRURGIE, 2018, 64 (05) : 355 - 363
  • [33] Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas
    Goutagny, Stephane
    Raymond, Eric
    Esposito-Farese, Marina
    Trunet, Stephanie
    Mawrin, Christian
    Bernardeschi, Daniele
    Larroque, Beatrice
    Sterkers, Olivier
    Giovannini, Marco
    Kalamarides, Michel
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (02) : 313 - 320
  • [34] Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas
    Stéphane Goutagny
    Eric Raymond
    Marina Esposito-Farese
    Stéphanie Trunet
    Christian Mawrin
    Daniele Bernardeschi
    Béatrice Larroque
    Olivier Sterkers
    Marco Giovannini
    Michel Kalamarides
    Journal of Neuro-Oncology, 2015, 122 : 313 - 320
  • [35] Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation
    Zhao, Fu
    Wang, Bo
    Yang, Zhijun
    Zhou, Qiangyi
    Li, Peng
    Wang, Xingchao
    Zhang, Jing
    Zhang, Junting
    Liu, Pinan
    JOURNAL OF NEURO-ONCOLOGY, 2018, 138 (02) : 417 - 424
  • [36] DIFFUSION MRI-BASED FIBER TRACKING IN HEALTHY AND BRAIN INJURY PATIENTS: A COMPARISON OF DIFFERENT SOFTWARE TOOLS
    Lucconi, Giulia
    Romeo, Chiara
    Bonetti, Roberto
    Cenni, Patrizia
    Scrittori, Nicoletta
    JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY, 2015, 15 (02)
  • [37] Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: An analysis of tumor control, complications, and hearing preservation rates - Comments
    Pollock, Bruce E.
    Golfinos, John G.
    Roland, J. Thomas
    Narayana, Ash
    Gutin, Philip H.
    Noren, Georg
    Chen, Joseph C. T.
    Goodkin, Robert
    NEUROSURGERY, 2007, 60 (03) : 468 - 470
  • [38] Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis
    Huang, Qiao
    Zhai, Si-Jia
    Liao, Xing-Wei
    Liu, Yu-Chao
    Yin, Shi-Hua
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [39] Schwannomatosis associated schwannomas show a different NF2 mutational spectrum compared to Neurofibromatosis type 2 patients
    Paganini, I.
    Capone, G. L.
    Putignano, A.
    Sestini, R.
    Gensini, F.
    Porfirio, B.
    Marozza, A.
    Papi, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 450 - 450
  • [40] THE MAYO CLINIC MULTIDISCIPLINARY NF2 CLINIC EXPERIENCE OF BEVACIZUMAB IN NEUROFIBROMATOSIS TYPE 2-RELATED SCHWANNOMATOSIS PATIENTS WITH VESTIBULAR SCHWANNOMAS
    Webb, M. J.
    Webb, L. M.
    Van Gompel, J. J.
    Link, M. J.
    Neff, B. A.
    Carlson, M. L.
    Driscoll, C. W.
    Ruff, M. W.
    Anderson, K. A.
    Neth, B. J.
    Kizilbash, S. H.
    Uhm, J. H.
    Lane, J. I.
    Benson, J. C.
    Blezek, D. J.
    Mehta, P. M.
    Bathla, G.
    Sener, U. T.
    NEURO-ONCOLOGY, 2023, 25